共 209 条
[1]
Xing M(2013)Molecular pathogenesis and mechanisms of thyroid cancer Nat Rev Cancer 13 184-99
[2]
Xing M(2013)Progress in molecular-based management of differentiated thyroid cancer Lancet 381 1058-69
[3]
Haugen BR(2020)Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma Exp Ther Med 20 243-81
[4]
Schlumberger M(2018)Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System between Papillary and follicular thyroid Cancer Thyroid 28 976-20
[5]
Huang K(2016)Exploring the relationship between patient age and Cancer-specific survival in papillary thyroid Cancer: Rethinking Current Staging systems J Clin Oncol 34 4415-7
[6]
Gao N(2021)Impacts of the American Joint Committee on Cancer (AJCC) 8(th) edition tumor, node, metastasis (TNM) staging system on outcomes of differentiated thyroid cancer in Thai patients Heliyon 7 e06624-305
[7]
Bian D(2006)Increasing incidence of thyroid cancer in the United States, 1973–2002 JAMA 295 2164-66
[8]
Zhai Q(2017)Community of Population-based Regional Cancer R: Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014 Cancer Res Treat 49 292-308
[9]
Yang P(2016)Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers J Clin Invest 126 1052-34
[10]
Zhang Y(2017)Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer Oncogene 36 5296-406